[Various immunological parameters studied in patients with malignant brain tumor. Correlation between clinical stage and T cell subsets].
Inoue
I
I
Yoshida
J
J
Kato
K
K
Wakabayashi
T
T
Kobayashi
T
T
Kageyama
N
N
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000276:immunology; D001932:Brain Neoplasms / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005434:Flow Cytometry; D005910:Glioma / Q000276:immunology; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008223:Lymphoma / Q000276:immunology; D008297:Male; D008527:Medulloblastoma / Q000276:immunology; D008579:Meningioma / Q000276:immunology; D008875:Middle Aged; D013601:T-Lymphocytes / Q000145:classification* / Q000276:immunology; D013724:Teratoma / Q000276:immunology
D000911:Antibodies, Monoclonal; D007370:Interferon Type I